格隆汇12月11日|据路透,礼来首席执行官David Ricks周二表示,税收和监管改革以及药品可负担性是公司在特朗普政府下的政策重点。特朗普上周在佛罗里达州会见了Ricks和行业游说团体PhRMA的首席执行官,辉瑞首席执行官Albert Bourla也参与了会面。Ricks没有透露此次谈话的细节,也没有提供更多有关他所针对的具体改革的信息。他表示,过去四年来,美国的监管状况对制药行业产生了...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.